Health Tech Forward Event 2024

HERAN PARTNERS is a Belgian-based investment fund founded by Annie Vereecken together with Katleen Vandersmissen, Joris Mortelmans and Herman Verrelst within the sector of MedTech and Digital Health. With a clear focus on European HealthTech, the fund provides venture & growth capital accompanied by a strong network, expertise and mentorship to startups and scale-ups with a strong technology platform and market potential. We strive to have impact!

Operator of a chain of multi-specialty hospitals based in Milan, Italy. The company provides treatment across various medicine branches like pediatrics, psychology, urology, gynecology, diabetology, cardiology and others as well as offers various surgical treatments, thereby helping patients to overcome health issues and receive better care.

FirstWord Pharma supplies global news and intelligence to the pharmaceutical industry. The service provides the top industry news stories on a daily basis in a format that is quick and easy to access so that users can always be in-the-know about the latest news and developments in their industry.

Provider of venture capital financing services. The company is engaged in providing private equity and venture capital financing services to its clients operating in Germany, Poland and other European countries.

Provider of venture capital investment services intended to accelerate portfolio companies' growth. The company's venture capital investment services provides funding and investment to the nations budding entrepreneurs, enabling clients to secure capital for their projects.

Developer of artificial intelligence and computer vision-based monitoring devices designed to track baby sleep behavior and patterns. The company's devices have a camera that monitors and analyzes sleep patterns in real-time, offering sleep insights, behavioral analysis, expert advice and nightly video summaries, enabling parents to take care of their children through advanced and innovative technologies.

Operator of a health technology company intended to advance connected care and accelerate research and therapies. The company's platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive, predictive care and research and offers a blend of medical expertise and has partnered with several leading healthcare institutes to measure and improve outcomes for diseases, enabling healthcare professionals to use data to deliver good health for all.

Developer of a cell therapy technology designed for the treatment of patients after a stem cell transplant to prevent rejection reactions. The company's technology focuses on the development of clinical testing of cell therapeutics for the suppression of transplant rejection and autoimmunity and the portfolio of cell therapy, enabling patients to prevent the fatal consequences of rejection, significantly improving their quality of life, and also opening up to many therapy options.

Developer of a women's health platform designed to reshape gynecological diagnostics. The company offers services that envision the gynecological fluid as the next step in liquid biopsy in gynecology, a comprehensive diagnostics portfolio to drive innovation and positive change in women's healthcare, WomEC, an IVD (in vitro diagnostics) for EC and additional products related to EC diagnosis (endometrial cancer screening test for high-risk population, but also to tackle other gynecological diseases affecting the lower gynecological tract, such as endometriosis and ovarian cancer, enabling users with the development and validation stages of innovative systems for women's health following quality and regulatory requirements, including prototype development, clinical validation and utility, and IP (Intraperitoneal injection) improvement.

We are a European headquartered hub for litigation, transactions and advice throughout the world and have remained fiercely independent since we first began in 1837. This means we are free to partner with the best people in any jurisdiction for each client need, or work with your existing relationships. We don’t work to billing targets. This ensures you get the right combination of experts working as one, who take the time to share their different perspectives and find the right answer, no matter how difficult or novel the question is. It’s a rare approach that defines the quality of our advice. And because we like to recruit inquisitive minds, many with science and technology backgrounds, we live and breathe your business, can talk the same language and have a keen eye on the future. We enjoy getting to the heart of the matter with advice that is simple to understand and easy to use. Like any business we have evolved with time, but our focus and spirit have remained as resolute as the quality of our advice and as inimitable as the experience we deliver. We are Bristows, seeing things differently for those shaping tomorrow.